SOLID TUMOR CANCER
Clinical trials for SOLID TUMOR CANCER explained in plain language.
Never miss a new study
Get alerted when new SOLID TUMOR CANCER trials appear
Sign up with your email to follow new studies for SOLID TUMOR CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New injection JL19001 enters early human testing for tough cancers
Disease control Not yet recruitingThis early-stage study tests a new drug called JL19001 in people with advanced solid tumors or a type of blood cancer (B-cell non-Hodgkin lymphoma) that has come back or not responded to standard treatments. The main goal is to find a safe dose and check for side effects. About 1…
Matched conditions: SOLID TUMOR CANCER
Phase: PHASE1 • Sponsor: Jecho Biopharmaceuticals Co., Ltd. • Aim: Disease control
Last updated May 26, 2026 03:10 UTC
-
New drug trains immune system to eat cancer cells in early trial
Disease control Not yet recruitingThis early-phase trial tests a new drug that helps the immune system recognize and attack cancer cells by blocking a 'don't eat me' signal. It is for people with advanced solid tumors that have not responded to standard treatments. The main goal is to check safety and find the ri…
Matched conditions: SOLID TUMOR CANCER
Phase: PHASE1 • Sponsor: West China Hospital • Aim: Disease control
Last updated May 22, 2026 13:51 UTC
-
New cancer drug QLS5212 enters first human trial
Disease control Not yet recruitingThis early-phase study tests a new drug called QLS5212 in 100 people with advanced solid tumors that cannot be removed by surgery or have spread. The main goals are to find a safe dose and check for side effects. Researchers will also look at how the drug moves through the body a…
Matched conditions: SOLID TUMOR CANCER
Phase: PHASE1 • Sponsor: Qilu Pharmaceutical Co., Ltd. • Aim: Disease control
Last updated May 19, 2026 12:00 UTC
-
Could cutting vitamin B6 boost cancer immunotherapy?
Symptom relief Not yet recruitingThis early-phase study tests whether a diet that strictly limits vitamin B6 can make immunotherapy work better for people with solid tumors. About 20 adults aged 18-80 will follow this special diet for 6 weeks while continuing their regular immunotherapy. The main goal is to chec…
Matched conditions: SOLID TUMOR CANCER
Phase: PHASE1 • Sponsor: West China Hospital • Aim: Symptom relief
Last updated May 26, 2026 03:08 UTC